Trastuzumab 150mg Injection$124.00
1–9 boxes
$124.00 each
10–24 boxes
8% off
25+ boxes
10% off
Trastuzumab 150mg Injection
SKU GME1477Oncology Care
Product Introduction
Trastuzumab 150mg is a HER2-directed monoclonal antibody used in HER2-positive breast cancer and selected advanced gastric or gastro-oesophageal cancers. HER2 testing identifies cancers that may benefit.
How to use
The reconstituted medicine is diluted for intravenous infusion. The first infusion is generally given over about 90 minutes, with later infusions shortened if tolerated. Weekly and three-weekly regimens use different doses.
How it works
Trastuzumab binds HER2 on tumour cells, reduces growth signalling and helps immune cells recognise and attack the cancer.
Side effects
Fever, chills, headache, nausea and infusion reactions can occur. Reduced heart pumping function and serious lung reactions are important risks.
Important information
Heart function is assessed before and during treatment, especially with prior anthracycline exposure. Effective contraception is needed during treatment and for 7 months after the last dose.
Uses
- HER2-positive breast cancer and selected HER2-positive advanced gastric or gastro-oesophageal cancers.
Benefits
Can reduce recurrence or progression when incorporated into a suitable HER2-directed cancer regimen.
Why is HER2 testing needed?
The target protein must be present at the required level or genetic pattern for the proposed treatment setting.
Is it the same as trastuzumab emtansine or deruxtecan?
No. Those are antibody-drug conjugates with different doses, indications and toxicities.
Why are heart scans repeated if I have no symptoms?
A decline in pumping function can appear before breathlessness or swelling and may change the treatment plan.
Is every trastuzumab product injected under the skin?
No. These powder-vial presentations are for intravenous infusion; dedicated subcutaneous products use different formulations.
HER2: a growth receptor present at high levels in some tumours. Monoclonal antibody: a targeted immune-system protein. LVEF: a measure of the heart’s pumping function.; AR: Trastuzumab 150mg حقن; FR: Trastuzumab 150mg injection; PT: Trastuzumab 150mg injeção; ES: Trastuzumab 150mg inyección; RU: Trastuzumab 150mg инъекция; ID: Trastuzumab 150mg suntikan; VI: Trastuzumab 150mg thuốc tiêm; MS: Trastuzumab 150mg suntikan; TL: Trastuzumab 150mg iniksyon; ZH-SG: Trastuzumab 150mg 注射剂